India vs Moldova: Average cost of drugs for extensively drug-resistant tuberculosis

India

1,203 constant 2022 US$

in 2024

Moldova

1,400 constant 2022 US$

in 2024

India rank

39th

Moldova rank

36th

Average cost of drugs for extensively drug-resistant tuberculosis over time

Moldova currently reports 1,400 constant 2022 US$ against 1,203 constant 2022 US$ in India, a difference of 197 constant 2022 US$.

That makes Moldova's figure about 1.2 times India's.

The two have swapped places 3 times across 8 shared years of data; in 2017 it was India ahead.

India ranks 39th and Moldova ranks 36th of 56 countries.

Indicator: Average cost of drugs for extensively drug-resistant tuberculosis
Unit: constant 2022 US$
Source: WHO (2025) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 56 places, 394 data points, 2017–2024
Last refreshed: 07 August 2026

Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.